TOMM40 Association With Alzheimer Disease Tales of APOE and Linkage Disequilibrium

被引：21
|
作者：
Guerreiro, Rita J. [1 ]
Hardy, John [1 ]
机构：
[1] UCL Inst Neurol, Reta Lilla Weston Labs, Dept Mol Neurosci, London WC1N 3BG, England
来源：
ARCHIVES OF NEUROLOGY | 2012年 / 69卷 / 10期
基金：
英国医学研究理事会;
关键词：
APOLIPOPROTEIN-E; GENETIC-VARIATION; ONSET; ALLELE; EXPRESSION; LENGTH; LOCUS; AGE;
D O I：
10.1001/archneurol.2012.1935
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1243 / 1244
页数：2
相关论文
共 50 条
  • [1] TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects
    Mise, Ayano
    Yoshino, Yuta
    Yamazaki, Kiyohiro
    Ozaki, Yuki
    Sao, Tomoko
    Yoshida, Taku
    Mori, Takaaki
    Mori, Yoko
    Ochi, Shinichiro
    Iga, Jun-ichi
    Ueno, Shu-ichi
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (03) : 1107 - 1117
  • [2] TOMM40 and APOE variants synergistically increase the risk of Alzheimer’s disease in a Chinese population
    Zheng Zhu
    Yang Yang
    Zhenxu Xiao
    Qianhua Zhao
    Wanqing Wu
    Xiaoniu Liang
    Jianfeng Luo
    Yang Cao
    Minhua Shao
    Qihao Guo
    Ding Ding
    [J]. Aging Clinical and Experimental Research, 2021, 33 : 1667 - 1675
  • [3] Alzheimer's disease cortical morphological phenotypes are associated with TOMM40′523-APOE
    Honea, Robyn A.
    Hunt, Suzanne
    Lepping, Rebecca J.
    Vidoni, Eric D.
    Morris, Jill K.
    Watts, Amber
    Michaelis, Elias
    Burns, Jeffrey M.
    Swerdlow, Russell H.
    [J]. NEUROBIOLOGY OF AGING, 2023, 132 : 131 - 144
  • [4] TOMM40 and APOE: Requirements for replication studies of association with age of disease onset and enrichment of a clinical trial
    Roses, Allen D.
    Lutz, Michael W.
    Crenshaw, Donna G.
    Grossman, Iris
    Saunders, Ann M.
    Gottschalk, W. Kirby
    [J]. ALZHEIMERS & DEMENTIA, 2013, 9 (02) : 132 - 136
  • [5] Alzheimer's Disease Susceptibility Genes APOE and TOMM40, and Hippocampal Volumes in the Lothian Birth Cohort 1936
    Lyall, Donald M.
    Royle, Natalie A.
    Harris, Sarah E.
    Bastin, Mark E.
    Munoz Maniega, Susana
    Murray, Catherine
    Lutz, Michael W.
    Saunders, Ann M.
    Roses, Allen D.
    Hernandez, Maria C. del Valdes
    Starr, John M.
    Porteous, David. J.
    Wardlaw, Joanna M.
    Deary, Ian J.
    [J]. PLOS ONE, 2013, 8 (11):
  • [6] The biological foundation of the genetic association of TOMM40 with late-onset Alzheimer's disease
    Zeitlow, Kahli
    Charlambous, Lefko
    Ng, Isaac
    Gagrani, Sonal
    Mihovilovic, Mirta
    Luo, Shuhong
    Rock, Daniel L.
    Saunders, Ann
    Roses, Allen D.
    Gottschalk, W. Kirby
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2017, 1863 (11): : 2973 - 2986
  • [7] Understanding the genetics of APOE and TOMM40 and role of mitochondrial structure and function in clinical pharmacology of Alzheimer's disease
    Roses, Allen
    Sundseth, Scott
    Saunders, Ann
    Gottschalk, William
    Burns, Dan
    Lutz, Michael
    [J]. ALZHEIMERS & DEMENTIA, 2016, 12 (06) : 687 - 694
  • [8] TOMM40 Genetic Variants Cause Neuroinflammation in Alzheimer's Disease
    Chen, Yi-Chun
    Chang, Shih-Cheng
    Lee, Yun-Shien
    Ho, Wei-Min
    Huang, Yu-Hua
    Wu, Yah-Yuan
    Chu, Yi-Chuan
    Wu, Kuan-Hsuan
    Wei, Li-Shan
    Wang, Hung-Li
    Chiu, Ching-Chi
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [9] TOMM40 and APOE common genetic variants are not Parkinson's disease risk factors
    Peplonska, Beata
    Safranow, Krzysztof
    Gaweda-Walerych, Katarzyna
    Maruszak, Aleksandra
    Czyzewski, Krzysztof
    Rudzinska, Monika
    Barcikowska, Maria
    Zekanowski, Cezary
    [J]. NEUROBIOLOGY OF AGING, 2013, 34 (08) : 2078.e1 - 2078.e2
  • [10] Therapeutic considerations for APOE and TOMM40 in Alzheimers disease: A tribute to Allen Roses MD
    Sabbagh, Marwan Noel
    Pope, Evans
    Cordes, Laura
    Shi, Jiong
    DeCourt, Boris
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (01) : 39 - 44
12345